| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/08/2008 | CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/07/2008 | EP1918284A1 Hydrazinopyrimidines as cysteine protease inhibitors |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918277A2 Azulene compounds |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917963A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917255A2 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 05/07/2008 | EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors |
| 05/07/2008 | EP1917251A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917246A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 05/07/2008 | EP1789412B1 Crystalline alfuzosin base |
| 05/07/2008 | EP1761519B1 Indole derivatives as histamine receptor antagonists |
| 05/07/2008 | EP1603880B1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 05/07/2008 | EP1603874B1 G-lactam derivatives as prostaglandin agonists |
| 05/07/2008 | EP1601670B1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/07/2008 | EP1592680B1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1430049B1 Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101175750A Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 05/07/2008 | CN101175749A Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 05/07/2008 | CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 05/07/2008 | CN101175747A Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 05/07/2008 | CN100386321C Y-type second-order non-linear optical luminophor contg. triphenylamine, prepn. method and use thereof |
| 05/07/2008 | CN100386320C Triazine compounds, polymers comprising triazine structural units, and processes for the preparation of these polymers |
| 05/06/2008 | US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368569 Combining a strong base with a phenyl isonicotinamide in aprotic solvents to form a solutions, then reacting with a cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 05/06/2008 | US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists |
| 05/06/2008 | US7368476 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-ylethoxy)but-2-enoylamino]-ethoxy}-N-hydroxybenzamide hydrochloride; anticancer, bipolar disorders; inhibitors of histone deacetylase |
| 05/06/2008 | US7368467 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368464 Alkylating 4-amino-1,2,4-triazole with a stearically hindered methyl oxirane; chemical intermediates, fungicidal compositions for cereal diseases |
| 05/06/2008 | US7368463 Substituted 4-amino-1-benzylpiperidine compounds |
| 05/06/2008 | US7368453 Quinazolinone compounds with reduced bioaccumulation |
| 05/06/2008 | US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368447 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/06/2008 | US7368434 Alcoholism therapy |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2390649C 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/06/2008 | CA2217821C Benzopyrans and pharmaceutical compositions containing them |
| 05/02/2008 | WO2008051547A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008049919A2 Rho kinase inhibitors |
| 05/02/2008 | WO2008049585A1 Pyridazine derivatives |
| 05/02/2008 | WO2008019030A8 Modified azole compounds as antiinfective agents |
| 05/02/2008 | WO2007135293A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 05/02/2008 | CA2669111A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | CA2667235A1 Pyridazine derivatives |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103148 Preventing ventilator induced pneumonia; utilizing compounds having longer half life on mucosal surfaces |
| 04/30/2008 | EP1916246A2 An improved process for the preparation of olmesartan medoxomil |
| 04/30/2008 | EP1916240A1 Pyridazine derivatives |
| 04/30/2008 | EP1915368A1 Salts and polymorphs of a vergf-r inhibitor |
| 04/30/2008 | EP1915367A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1601664B1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 04/30/2008 | CN101171249A Method for producing indole derivative having piperidine ring |
| 04/30/2008 | CN101171248A 3-mono- and 3,5-disubstituted piperidine derivatives as renin inhibitors |
| 04/30/2008 | CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/30/2008 | CN101171015A Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 04/30/2008 | CN101168542A Method for preparing 1-[2-(2,4-difluorophenyl)-2,3-epoxypropyl]-1-hydro-1,2,4-triazole |
| 04/30/2008 | CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384833C Therapeutic chroman compounds |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384822C 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/30/2008 | CN100384421C N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
| 04/29/2008 | US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365093 Endothelin antagonists |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365082 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 04/29/2008 | US7365077 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine |
| 04/29/2008 | US7365072 Inhibitors of p38 |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365063 5-HT6 receptor and/or 5-HT2A receptor modulators; CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, sleep disorders, feeding disorders |
| 04/29/2008 | US7364804 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative |
| 04/29/2008 | CA2302445C New taxane derivatives |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | WO2008047849A1 Process for the production of 2- [ [4- t (2, 2-dimethyl-1, 3-dioxan-5-yl) methoxy] pyridin-2-yl] methylthio] -1h-benzimidazole |
| 04/24/2008 | WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 04/24/2008 | WO2008047224A1 Pyrazolyl-4-oxy-benzonitrile derivatives useful in treating endometriosis |
| 04/24/2008 | WO2008047201A2 Solid dispersion comprising a poorly water soluble drug |
| 04/24/2008 | WO2008046792A1 CRISTALLINE FORM OF THE RACEMIC METHYL-α-(2-CHLORPHENYL)-2-(6,7-DIHYDROTHIENO[3,2-C]PYRIDINE-5(4H)) ACETATE, METHOD FOR THE PRODUCTION AND USE THEREOF |
| 04/24/2008 | WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases |